Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc.Business Wire • 01/14/22
Deadline Tuesday Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 01/13/22
DNA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces January 18, 2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against of Ginkgo Bioworks Holdings, Inc. InvestorsPRNewsWire • 01/13/22
Tuesday Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 01/12/22
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DNA Investors of Upcoming Deadline and Urges Investors with Substantial Losses to Contact the FirmNewsfile Corp • 01/12/22
Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business ReviewPRNewsWire • 01/12/22
Ginkgo Bioworks Holdings, Inc. (DNA) Could Find Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 01/11/22
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNAPRNewsWire • 01/10/22
Ginkgo Bioworks Adopts Inscripta's Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing ThroughputBusiness Wire • 01/10/22
Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy CapsidsPRNewsWire • 01/10/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important January 18 Deadline in Securities Class Action Commenced by the Firm - DNA, SRNGPRNewsWire • 01/07/22
Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic HeparinPRNewsWire • 01/06/22
DNA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Ginkgo Bioworks Holdings, Inc. Shareholders of Securities Fraud Class Action LawsuitPRNewsWire • 01/05/22
Ginkgo Bioworks Announces Participation in 40th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/05/22
ROSEN, A TOP RANKED FIRM, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors to Secure Counsel Before Important January 18 Deadline in Securities Class Action Commenced by the Firm - DNA, SRNGPRNewsWire • 01/01/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors to Secure Counsel Before Important January 18 Deadline in First Filed Securities Class Action Commenced by the Firm - DNA, SRNGNewsfile Corp • 12/30/21
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Ginkgo Bioworks Holdings, Inc. (DNA) Investors with Substantial Losses to Contact the FirmPRNewsWire • 12/29/21
Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Launch Biotechnology Manufacturing Associates DegreePRNewsWire • 12/20/21
Concentric by Ginkgo and XpresCheck™ Confirm First North American Detections of Novel BA.3 Sublineage of Omicron Variant through CDC COVID-19 Air Travel Biosecurity ProgramPRNewsWire • 12/18/21
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Ginkgo Bioworks Holdings, Inc. (DNA) Investors and Encourages Investors to Contact the Firm Before January 18, 2022Business Wire • 12/17/21
